RBM5 and small cell lung carcinoma: Our group recently identified RBM5 targets using an endogenously RBM5-null SCLC cell line (S1 Table), GLC20 [24], from which three stable sublines—an empty vector control and two RBM5 expressing (T2 and C4)–had been generated [9].